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Abstract
Bordetella bronchiseptica chronically infects a wide range of mammals, and resides
primarily in the nasal cavity of the infected host. Multiple virulence factors of
Bordetella species have been studied in the context of lower respiratory tract
infections, but relatively less is known about the bacterial life cycle in the nasal
cavity. Evidences were discovered for Bvg intermediate (Bvg
i) phase expression
in vivo and that the major adhesin ﬁlamentous hemagglutinin plays a major role in
the colonization of B. bronchiseptica in the unciliated olfactory epithelia of the
nasal cavity.
Introduction
Bordetella pertussis, Bordetella parapertussis and Bordetella
bronchiseptica are closely related Gram-negative species that
colonize the upper respiratory tract of mammals and mainly
cause pathogenic symptoms in the lower respiratory tract.
Bordetella pertussis and most B. parapertussis strains only
infect humans and generally cause acute respiratory diseases
(Bjrnstad & Harvill, 2005). Bordetella bronchiseptica often
causes persistent chronic infections in a wide range of
mammalian host and colonizes the hosts for their lifetimes
(Mattoo & Cherry, 2005). Despite the differences in host
niches and symptoms due to infections by the Bordetella
species, most virulence factors are highly conserved.
A majority of Bordetella virulence factors are transcrip-
tionally controlled by a two-component system BvgAS
(Bordetella virulence genes). The response regulator BvgA
has different binding speciﬁcities to certain promoters of
virulence factors depending on its phosphorylation status as
modulated by the sensor histidine kinase BvgS (Cotter &
Jones, 2003). In the virulent Bvg
1 phase, toxins/toxin
delivery systems such as pertussis toxin, adenylate cyclase/
hemolysin bifunctional toxin (CyaA), dermonecrotic toxin,
and type III secretion system are being expressed. Adhesins
such as ﬁlamentous hemagglutinin (FHA) and ﬁmbriae are
also highly expressed. In the avirulent Bvg
 phase, the
virulence factors are not expressed (Mattoo & Cherry,
2005). Bvg modulations are thought to affect proﬁles of
gene transcriptions in a gradual range of changes (Cum-
mings et al., 2006). Between Bvg
1 and Bvg
phases is at least
one distinct phase named the Bvg intermediate phase (Bvg
i)
(Cotter & Miller, 1997), expressing a different set of gene
products from Bvg
1 and Bvg
 phases. Genes such as bipA
are upregulated speciﬁc to the Bvg
i phase, as well as the
adhesins such as FHA and ﬁmbriae that are expressed at
both Bvg
1 and Bvg
i phases.
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cells are well-characterized and are the primary causes for
in vitro cytotoxicity (Cotter et al., 1998; Yuk et al., 2000;
Vojtova et al., 2006). In addition, they interfere with the host
immune systems to facilitate the successful infection of the
host (Skinner et al., 2004; Reissinger et al., 2005; Vojtova
et al., 2006). FHA possesses at least four binding domains
involved in attachment including the Arg–Gly–Asp (RGD)
triplet, the leukocyte response integrin/integrin-associated
protein (LRI/IAP) complex, the complement receptor type 3
(CR3) and the carbohydrate recognition domain (CRD)
(Relman et al., 1990; Saukkonen et al., 1991; Prasad et al.,
1993; Ishibashi et al., 1994). FHA has been characterized as
the major adhesin that mediates binding to the cilia of the
respiratory epithelial cells by the CRD domain (Prasad et al.,
1993). In addition, it was previously shown that FHA is
largely responsible for mediating bioﬁlm formation (Irie
et al., 2004).
AmajorityofthereportedresearchonBordetellapathogen-
esis has focusedon the infectionof the lower respiratory tract.
However, the primary host reservoir for B. bronchiseptica
colonization is thought to be the nasal cavity. Bvg phase
regulation is sensitive to temperature (Cotter & Jones,
2003), with the Bvg
1 phase being expressed at 371C while
the Bvg
 phase is predominant at 251C and below. The
mammalian mucosal temperature in the nasal cavity has
been estimated to be 301C (Jacky, 1980), which supports a
Bvg
i phase growth (Williams et al., 2005). In the Bvg
i phase,
toxins are not expressed, but the adhesins are. We report in
this study that FHA plays a major role in the colonization of
the nasal cavity, and provide indirect evidence that the
bacteria are in the Bvg
i phase in the nose.
Materials and methods
Bacterial strains and growth conditions
Bordetella bronchiseptica strains RB50 [wild type (WT)],
RB53 (Bvg
1 phase-locked mutant), RB53i (Bvg
i phase-
locked mutant), and RBX9 (DfhaB) were previously re-
ported and characterized (Cotter & Miller, 1994, 1997;
Cotter et al., 1998). Bordetella bronchiseptica strains were
propagated in Stainer–Scholte (Stainer & Scholte, 1970)
liquid medium or on BG agar (Becton Dickinson) supple-
mented with deﬁbrinated sheep blood at 371C.
Animal colonization
High-dose intranasal infections of anesthetized mice and
recovery of bacteria were performed as previously described
(Harvill et al., 1999) and at least three mice per experiment
were used. C57/BL6 mice aged 6–10 weeks old were
obtained from the National Cancer Institute and housed in
insulator cages and cared for in accordance with Institu-
tional Animal Care and Use Committee-approved protocols
at the University of Pennsylvania School of Medicine animal
facility. For tissue sectioning, sacriﬁced mice were bled by
cardiac puncture before decapitation. For bacterial counts,
CFU were determined by plating serially diluted homoge-
nized lungs and vortexed trachea and nasal cavity tissue
materials.
Tissue sections
Soft tissues were surgically removed from the skulls of
decapitated heads. The skulls were then immersed in 4%
paraformaldehyde phosphate-buffered saline (PBS) solution
for 24h, gently washed with water, and decalciﬁed in Decal
solution (Decal Chemical Corp) for 24h. Skulls were then
imbedded in Tissue-Tek O.C.T. (Sakura) before freezing in
2-methylbutane immersed in liquid nitrogen. Samples were
sectioned at 10mm thickness with cryotome blades and
mounted on glass microscopy slides.
Immunofluorescence
Frozen sections were ﬁxed in acetone at 41C for 10min.
They were then rehydrated in PBS, incubated in 0.1%
sodium borohydride for 15min. Sera from three mice
infected with WT B. bronchiseptica for 100 days were pooled
after retro-orbital bleeding and centrifuging and used as
primary antibodies for the stains. Secondary antibodies used
were Alexa Fluor 594-conjugated goat anti-mouse IgG
(Molecular Probes). Samples were incubated with each
solution of antibodies diluted 1:500 in PBS for 30min each
at room temperature. After each incubation step, samples
were washed three times with PBS.
Hematoxylin & eosin (H&E) staining
Frozen sections were ﬁrst washed in water for 3min. They
were then stained with hematoxylin solution (Surgipath) for
2min. followed by a wash step under running tap water for
2min. The slides were exposed to 50%ethanol for 1min and
then stained with eosin solution (Surgipath) for 1min. The
slides were rehydrated in alcohol ascending battery (from
70% to 100%) 1min per step. Slides were then cleared with
xyline (Surgipath) and a coverslip was applied using
Permount medium (Fisher).
Microscopy
All ﬂuorescence images were taken using Improvision Open
Lab software and a Leica DM R epiﬂuorescence microscope.
Deconvolution was performed on all images using Improvi-
sion Volocity.
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The biology of B. bronchiseptica in the nasal cavities of
infected hosts has not been extensively characterized. From
previous reports, Bvg
 phase-locked mutants were comple-
tely deﬁcient in colonization (Cotter & Miller, 1997), and
DfhaB mutants (functional deletion of FHA) had lower CFU
recovered from dissected nasal cavity tissue materials (Cotter
et al., 1998). To investigate colonization patterns throughout
the nasal cavity, tissue sections were carried out at different
intervals of the murine skulls along the anterial–posterial
axis. The different section intervals, based on a previous
histological description (Uraih & Maronpot, 1990), were
examined according to structural hallmarks at each
region of the nasal cavity. Level 1 is the most anterior region
of the nasal cavity, closest to the nares. The most signiﬁcant
differences between the different levels are the types of
epithelial cells lining the mucosa. The primary observation
is that there is a signiﬁcant transition from ciliated
respiratory epithelia to the nonciliated olfactory epithelia
qas progression is made into the nasal cavity toward the
posterior end of the skull. The epithelial cell types of
the speciﬁc nasal structures at various interval sections of
the nasal cavity, as described by an earlier study (Uraih &
Maronpot, 1990), are summarized in the ﬁrst four columns
of Table 1.
FHA mutants are unable to colonize nonciliated
olfactory epithelia
Upon studying WT and DfhaB-infected murine nasal cav-
ities by immunoﬂuorescence microscopy of tissue sections,
it was apparent that DfhaB mutants were incapable of
colonizing areas of the nasal cavity that consist primarily of
nonciliated olfactory epithelia (Table 1 and Fig. 1). Interest-
ingly, all strains of B. bronchiseptica were absent at the most
anterior end of the tissue sections (Level 1). The coloniza-
tion proﬁles of WT and DfhaB bacteria on the respiratory
and transitional epithelia at Level 2 and 2.5, however, were
identical (Table 1 and Fig. 2). Colonizing WT bacteria
ultimately grew into large three-dimensional structures after
7 days of infection (Fig. 1e). The enlarged image of one of
these microcolonies clearly shows that this is a structured
bacterial aggregate (Fig. 1h). By H&E stain of an adjacent
tissue section (Fig. 1i), there appear to be no superﬁcial
damages to the host epithelia in the area of B. bronchiseptica
colonization or any neutrophil inﬁltration that can contri-
bute to the observed microcolony structures. Similar micro-
colony formations have been observed previously invitro for
B. bronchiseptica bioﬁlms (Irie et al., 2004). It is possible that
the colonizing bacteria are growing in a bioﬁlm-like state.
FHA of Bordetella has been characterized to have speciﬁc
binding afﬁnities to the cilia of mammalian respiratory
cells (Smith et al., 2001). The absence of DfhaB in the
olfactory epithelia implicates that binding to these tissues
in vivo is FHA-dependent but not cilia-mediated. FHA
has also been shown to mediate binding to nonciliated
cells such as macrophages (Saukkonen et al., 1991), and
possesses at least four independent binding domains in-
volved in attachment (Mattoo & Cherry, 2005). As coloni-
zations of the nasal respiratory epithelia by WTand DfhaB
appear to be indistinguishable (Table 1 and Fig. 2), this
suggests that the binding to these ciliated cell types is
FHA-independent.
Further supporting the data observed by microscopy, the
quantities of DfhaB mutants recovered from dissected nasal
cavity tissue materials of mice were slightly less than those
from WT-infected animals at 7 days postinfection (Fig. 3;
p  0.0126), consistent with previous studies carried out in
rats (Cotter et al., 1998). At this time point, signiﬁcant
numbers of microcolonies in WT-infected samples but none
from samples infected by the DfhaB mutant could be
observed. The DfhaB bacteria recovered from the nasal
cavity probably represented those that were colonizing the
nasal respiratory epithelium. It is unclear why at 3 days
postinfection, WT and DfhaB mutants were recovered in
similar CFU. It is possible that the enlargement of the
microcolony structures is required to reﬂect differences in
the log scale.
Table 1. Comparison of colonization proﬁles between WTand DfhaB mutant in the nasal cavity
Level Location Epithelia type Ciliated? WTcolonization DfhaB colonization
1 Septum Respiratory Yes No No
Turbinates (naso- and maxillo-) Respiratory Yes No No
2 Septum Respiratory Yes Yes Yes
Turbinates (naso-) Transitional Sparsely Sparse Sparse
2.5 Septum Respiratory Yes Yes Yes
Turbinates (naso-) Olfactory No Yes No
3 Septum Olfactory No Yes No
Turbinates (ethmoid) Olfactory No Yes No
4 Septum Olfactory No Yes No
Turbinates (ethmoid) Olfactory No Yes No
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Fig. 2. Immunoﬂuorescence images of representative respiratory epithelia (Level 2.5 septum). Nasal cavity sections were prepared 3 (a–c) and 7 (d–f)
days postinfection by WTor DfhaB. Both WTand DfhaB were able to colonize the respiratory epithelia. Tissues were stained with mouse anti-Bordetella
bronchiseptica antibodies. Red=B. bronchiseptica. Green=pseudo-coloured tissue autoﬂuorescence. Magniﬁcation, 200. Scale bars, 16.75mm.
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Fig. 1. Immunoﬂuorescence images of representative olfactory epithelia (Level 2.5 naso-turbinates). (a–f) Nasal cavity sections were prepared 3 and 7
days postinfection by WTor DfhaB Bordetella bronchiseptica. Only WTwas able to colonize the olfactory epithelia. At 7 days postinfection, WT bacteria
formed large three-dimensional structures (microcolonies). Tissues were stained with mouse anti-B. bronchiseptica antibodies. Red, B. bronchiseptica.
Green, pseudo-coloured tissue autoﬂuorescence. Magniﬁcation, 200. Scale bars, 16.75mm. (g–h) High-resolution images (magniﬁcation, 630)
of colonizing WT bacteria. Corresponding areas (g) and (h) are boxed in (b) and (e), respectively. Scale bars, 10mm. (i) H&E stain of an adjacent
section to (e).
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i phase
in vivo
Bvg
i phase in vitro has previously been characterized as
important for surface attachment and bioﬁlm formation
(Irie et al., 2004). Bioﬁlm formation is FHA dependent,
leading one to investigate whether the in vitro phenotype is
related to observed bacterial colonization in vivo, which is
also FHA dependent and is in a microscopically bioﬁlm-like
state. The expression of the Bvg
i phase in vivo has been
controversial for some time, and it has been unclear as to
whether the Bvg
i phase is part of the pathogenic life cycle of
B. bronchiseptica (Vergara-Irigaray et al., 2005). The major
challenge has been that BipA (function and in vivo expres-
sion unknown) is currently the only characterized gene
product speciﬁc to the Bvg
i phase and not to the Bvg
1 or
Bvg
 phase (Stockbauer et al., 2001). WT-infected nasal
cavity tissue sections did not demonstrate the presence of
BipA when they were stained with antibodies raised against
BipA (data not shown). Since close examinations were not
carried out for nasal cavity B. bronchiseptica colonization in
the past, an attempt was made to investigate the speciﬁc Bvg
phase the bacteria were expressing in the nasal cavity. From
earlier studies, Bvg
 phase-locked strains are completely
deﬁcient in colonization of the host (Cotter & Miller, 1994)
and there are strong evidences that Bvg
 phase is not
expressedduring colonization (Cotter& Miller, 1994; Akerley
et al., 1995). Mice were then infected with Bvg
1 phase-
locked mutants (RB53). From the immunoﬂuorescence
images (Fig. 4a), it seemed that this mutant could form
microcolonies, but upon inspecting the H&E stain of an
adjacent section, it was discovered that it was caused
by major perturbations of the host epithelial tissue at the sites
of colonized bacteria (Fig. 4b) instead of by three-
dimensional bacterial aggregates. Various toxins such as
adenylate cyclase/hemolysin toxin and the type III secretion
effector(s) such as BteA/BopC (Panina et al., 2005; Kuwae
et al., 2006) that cause cytotoxicity to mammalian cells
are only expressed in the Bvg
1 phase. It is possible that the
expression of such toxins by RB53 in the nasal cavity was
causing such damage to the host tissue. Because such damage
to the host tissue by WT bacteria was not observed (Fig. 1e
and i), it is probable that WT B. bronchiseptica are not
expressing the Bvg
1 phase in the nasal cavity. In order to
conﬁrm whether colonized bacteria are expressing the Bvg
i
phase, mice were also infected with Bvg
i phase-locked
mutants (RB53i). However, consistent with previously pub-
lished results, RB53i colonizes the respiratory tract including
the nasal cavity poorly compared with WT (Cotter
& Miller, 1997), indicating that intact Bvg phase switch
mechanism is required for the successful maximum
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Fig. 3. DfhaB has colonization deﬁciency in the nasal cavity at 7 days
postinfection.Mice wereinfected with WTor DfhaB and sacriﬁced on the
days indicated. Short horizontal bar represents mean recovered CFU.
Dotted line represents the limit of detection. Presented ﬁgure is a
representative of at least six independent experiments.
(a) (b)
Fig. 4. (a) Immunoﬂuorescence image of naso-turbinate colonized with
RB53, 7 days postinfection. Magniﬁcation, 200. Scale bar, 16.75mm.
Corresponding H&E stain image (b) of an adjacent section is boxed.
Unlike Fig. 1(i), the sites of bacterial colonization are marked with major
histological alterations of the epithelium.
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195 Bordetella bronchiseptica in the nasal cavityestablishment of bacterial colonization. Because RB53i has
been characterized to hyper-aggregate (Cotter & Miller, 1997;
Stockbauer et al., 2001), traditional CFU counts on solid
media may be largely under-represented. However, there
appeared to be fewer bacterial microcolonies in the nasal
cavity compared with WT, complementing quantitative bac-
terial counts fromdissectedtissues (data not shown). Because
colonization levels are different between RB53i and WT,
direct comparison is difﬁcult to accomplish, indicating that
RB53i is not appropriate for in vivo studies of the Bvg
i phase.
Despite this difﬁculty, RB53i found in the nasal cavity was
found to form similar sizes of microcolony structures on the
nasal mucosa (data not shown), indicating that the lower
RB53iCFUwasnotduetoastructuralaggregationdefect,but
possibly due to insufﬁcient surface inoculation coverage
during infection, defect in initial attachment (highly unlikely,
giventheenhancedattachmentpropertiesofRB53i),defectin
competition against other resident species on the nasal
mucosa, and/or defect in survival of RB53i against host
immune system.
Absence of B. bronchiseptica was observed at Level 1
sections, possibly due to the lower temperature of the
surface mucosa near the nares, as the air is most likely
representative of ambient temperature. At such tempera-
ture, B. bronchiseptica expresses the Bvg
 phase and may be
incapable of attachment and other factors necessary to
establish colonization, as B. bronchiseptica was also not seen
infecting Level 1 sections at an earlier time point (Day 1
postinfection data not shown). Alternatively, B.bronchiseptica
may be experiencing niche competition against commensal
species heavily colonizing the areas of the nasal cavity closest
to the outside.
Discussion
Results from this study reveal interesting observations of
B. bronchiseptica colonization of the nasal cavity, an under-
researched site of B. bronchiseptica pathogenesis despite
being widely believed to be the primary site of environ-
mental reservoir. WT bacteria were observed to form three-
dimensional microcolony aggregates on nasal epithelia,
resembling in vitro bioﬁlm microcolonies (Irie et al., 2004).
While WT bacteria were able to colonize ciliated respiratory
epithelia and nonciliated olfactory epithelia, FHA mutants
were only able to colonize ciliated respiratory epithelia. This
result indicates that FHA is an important factor for adhesion
to nonciliated epithelia, but adhesion to ciliated epithelia is
FHA independent. FHA has been associated with cilia
adhesion in previous publications (Smith et al., 2001), but
all studies have been carried out with tracheal ciliated
epithelia cells (Edwards et al., 2005). Based on the discre-
pancies between the results described in this report and
previous publications, it is highly likely that there are
physiological differences between the cilia found in the nasal
cavity and the trachea. However, no publications could be
found comparing the two, as there are very few studies
focusing on cell biology of the nasal cavity epithelia. FHA
adhesion to ciliated nasal epithelial cells (not exclusively to
cilia themselves) has been suggested previously (Register &
Ackermann, 1997), but in vitro data on cultured nasal
epithelia might not be completely representative of in vivo
host–pathogen interactions.
FHA-dependent aggregation and adhesion have been
demonstrated for bioﬁlm formation in vitro. Because max-
imal bioﬁlm formation has been observed when B. bronch-
iseptica is expressing the Bvg
i phase (Irie et al., 2004), and
the bacterial microcolonies found on the nasal epithelial
cells closely resembled bioﬁlm microcolonies, it was next
examined whether B. bronchiseptica are expressing the Bvg
i
phase in the nasal cavity in vivo. Bvg
i phase-locked mutants
have colonization deﬁciency, indicating the importance of
intact Bvg phase variation mechanisms for proper bacterial
colonization in the respiratory tract, most likely very early
postinoculation in the infective cycle of the pathogen.
Furthermore, antibodies raised against the only character-
ized Bvg
i phase-speciﬁc marker protein, BipA, failed to react
with bacterial aggregates observed in the nasal cavity tissue
sections. BipA expression in vivo has been investigated in
previous studies, but deﬁnitive evidence for its expression
has not been demonstrated (Vergara-Irigaray et al., 2005). It
is therefore still unclear whether BipA can be used as an
appropriate Bvg
i phase marker for B. bronchiseptica found
in vivo. Lacking tools for direct Bvg
i phase examination,
inspections focusing on Bvg
 and Bvg
1 phases were im-
perative. Consistent with previous publications from other
groups, Bvg
phase-locked mutants are completely deﬁcient
in establishing colonization in the respiratory tract. Bvg
1
phase-locked mutants appeared to colonize the nasal cavity
similar to WT, but close examination of infected tissues
revealed major alterations of the epithelial lining, as WT-
infected tissues were indistinguishable with uninfected
epithelia. From these results, it can be concluded that
B. bronchiseptica found in the nasal cavity are expressing
neither Bvg
1 nor Bvg
 phases, and therefore indirectly
suggests the expression of the Bvg
i phase. However, the
possibility that B. bronchiseptica are expressing an entirely
different Bvg phase in vivo (Bvg
vivo phase) from the Bvg
phase variation continuum well-described from in vitro
studies cannot be excluded. Bvg
vivo is likely to be BvgAS
dependent, and have a ‘rheostat-like gradual control,’similar
to Bvg phase variation observed in vitro.
If B. bronchiseptica are growing in a bioﬁlm-like state in
the nasal cavity, bacteria may be detaching from nasal
epithelia as part of a bioﬁlm developmental life cycle. Many
in vitro bioﬁlm systems have been observed to cycle through
steps of surface attachment, bioﬁlm formation and
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cells from the main bioﬁlm body (Hall-Stoodley & Stoodley,
2005). Bordetella bronchiseptica bioﬁlm development can
also be envisioned to follow similar life cycles. The only
proposed roles of Bvg
i phase has been attributed to trans-
mission of Bordetella from one host to another (Cotter &
Miller, 1997), and such detachment may contribute to
transmission if bacteria exit the respiratory tract, or to the
persistent chronic nature of B. bronchiseptica infection if
bacteria are inhaled into the lower respiratory tract (Irie
et al., 2004). Adhesion to cilia in the nasal cavity may also be
critical for bacterial spread within and across hosts since the
maximum ﬂuid ﬂow dynamics can be expected on ciliated
surfaces, and shear force has been shown to playa signiﬁcant
role in bioﬁlm detachment and dispersion (Hall-Stoodley &
Stoodley, 2005).
Nasal mucosal surface has unique properties that make
drug treatments less effective, such as lower diffusion rates
(Donovan et al., 1990) and rapid mucociliary clearance
(Schipper et al., 1991). Clearance of chronic persistent
pathogenic species colonizing the nasal cavity is a medically
challenging future issue. Further studies of B. bronchiseptica
in the nose will beneﬁt in better understanding of long-term
colonizations of pathogens in the hosts.
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